drugset / Trial / NCT00017563

Combination Chemotherapy Followed by Surgery in Treating Patients With Localized Prostate Cancer

NCT00017563

NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug and giving chemotherapy before surgery may shrink the tumor so that it can be removed during surgery. PURPOSE: Phase I/II trial to study the effectiveness of combination chemotherapy followed by surgery in treating patients who have localized prostate cancer.

Timeline

Start
2000-09
Primary completion
2010-05
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Mitoxantrone Small molecule 2 mg/m2
Subject Mitoxantrone Small molecule 6 mg/m2
Background Docetaxel Small molecule 35 mg/m2 Intravenous

Indications